Skip to main content

Table 1 Age-standardized prevalence rate of statin use in secondary prevention

From: Time trends in statin use and incidence of recurrent cardiovascular events in secondary prevention between 1999 and 2013: a registry-based study

Group ASPR of statin use in 1999 Summary Trend 1 Trend2 Trend3
AAPC Years APC Years APC Years APC
Total 8.4% 12.5 [10.9; 14.1]* 1999–2005 25.4 [21.8; 29.0]* 2005–2013 3.7 [1.7; 5.6]*   
 Women 6.5% 12.6 [10.9; 14.3]* 1999–2005 25.0 [21.3; 28.8]* 2005–2013 4.1 [2.1; 6.2]*   
  50–59 7.6% 8.3 [5.7; 10.8]* 1999–2005 21.0 [15.5; 26.9]* 2005–2013 −0.4 [− 3.4; 2.6]   
  60–69 13.6% 7.3 [5.1; 9.6]* 1999–2006 15.2 [11.4; 19.2]* 2006–2013 −0.1 [− 3.4; 3.3]   
  70–79 6.6% 14.0 [12.1; 16.0]* 1999–2004 31.0 [27.7; 34.4]* 2004–2008 11.2 [5.0; 17.8]* 2008–2013 1.3 [− 1.3; 3.9]
  80+ 1.2% 23.2 [17.3; 29.4]* 1999–2005 40.0 [26.8; 54.5]* 2005–2013 11.9 [5.0; 19.3]*   
 Men 10.0% 12.3 [10.7; 13.9]* 1999–2005 25.4 [21.8; 29.0]* 2005–2013 3.4 [1.5; 5.3]*   
  50–59 18.3% 6.5 [4.7; 8.4]* 1999–2005 17.2 [13.2; 21.4]* 2005–2013 −0.8 [− 3.0; 1.5]   
  60–69 12.7% 10.7 [9.0; 12.4]* 1999–2005 24.9 [21.2; 28.8]* 2005–2013 1.0 [− 0.9; 3.1]   
  70–79 7.6% 15.5 [13.7; 17.4]* 1999–2005 29.2 [25.1; 33.3]* 2005–2013 6.2 [4.1; 8.4]*   
  80+ 0.8% 28.0 [22.8; 33.3]* 1999–2005 59.1 [46.5; 72.9]* 2005–2013 8.7 [3.0; 14.6]*   
  1. *p < 0.05; ASPR age-standardized prevalence rate, AAPC average annual percentage change, APC annual percentage change